表紙
市場調查報告書
商品編碼
1031284

臉用注射劑的全球市場(2021年∼2025年)

Global Facial Injectables Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

臉用注射劑的市場規模在2021年∼2025年的預測期間內,預計將以8.91%的年複合成長率增長,並成長到27億6,000萬美元。

臉用注射劑市場相關之本報告提供整體分析,市場規模與預測,趨勢,涵括成長要素,課題,以及約25位供應商的供應商分析。

市場成長的主要因素有從侵入性手術到微創和非侵入性手術的轉變以及消費者審美意識不斷增強。

這份報告提供臉用注射劑的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,各產品·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模(2020年)
  • 市場規模預測(2020年∼2025年)

波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各產品的市場區隔

  • 市場區隔
  • 各產品比較
  • 肉毒桿菌
  • 皮膚填充劑
  • 各產品的市場機會

客戶形勢

  • 客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 地區形勢的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AbbVie Inc.
  • Bloomage Biotechnology Corp Ltd.
  • Croma Pharma GmbH
  • Galderma SA
  • Hangzhou Techderm Biological Products Co. Ltd.
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Prollenium Medical Technologies Inc.
  • Sinclair Pharma Group
  • Suneva Medical

附錄

目錄
Product Code: IRTNTR70867

Technavio has been monitoring the facial injectables market and it is poised to grow by $ 2.76 bn during 2021-2025, progressing at a CAGR of 8.91% during the forecast period. Our report on the facial injectables market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the shift from invasive to minimally invasive and non-invasive procedures and increase in beauty consciousness among consumers. In addition, the shift from invasive to minimally invasive and non-invasive procedures is anticipated to boost the growth of the market as well.

The facial injectables market analysis includes the product segment and geographic landscape.

Technavio's facial injectables market is segmented as below:

By Product

  • Botox
  • Dermal fillers

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing demand for facial injectables among older populationas one of the prime reasons driving the facial injectables market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on facial injectables market covers the following areas:

  • Facial injectables market sizing
  • Facial injectables market forecast
  • Facial injectables market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading facial injectables market vendors that include AbbVie Inc., Bloomage Biotechnology Corp Ltd., Croma Pharma GmbH, Galderma SA, Hangzhou Techderm Biological Products Co. Ltd., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Prollenium Medical Technologies Inc., Sinclair Pharma Group, and Suneva Medical. Also, the facial injectables market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Botox - Market size and forecast 2020-2025
    • Dermal fillers - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer landscape
    • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • AbbVie Inc.
    • Bloomage Biotechnology Corp Ltd.
    • Croma Pharma GmbH
    • Galderma SA
    • Hangzhou Techderm Biological Products Co. Ltd.
    • Medytox Inc.
    • Merz Pharma GmbH and Co. KGaA
    • Prollenium Medical Technologies Inc.
    • Sinclair Pharma Group
    • Suneva Medical
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Botox - Market size and forecast 2020-2025 ($ million)
  • 24: Botox - Year-over-year growth 2020-2025 (%)
  • 25: Dermal fillers - Market size and forecast 2020-2025 ($ million)
  • 26: Dermal fillers - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share By Geographical Landscape 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity By Geographical Landscape ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: AbbVie Inc. - Overview
  • 48: AbbVie Inc. - Product and service
  • 49: AbbVie Inc. - Key offerings
  • 50: AbbVie Inc. - Key customers
  • 51: AbbVie Inc. - Segment focus
  • 52: Bloomage Biotechnology Corp Ltd. - Overview
  • 53: Bloomage Biotechnology Corp Ltd. - Business segments
  • 54: Bloomage Biotechnology Corp Ltd. - Key offerings
  • 55: Bloomage Biotechnology Corp Ltd. - Key customers
  • 56: Bloomage Biotechnology Corp Ltd. - Segment focus
  • 57: Croma Pharma GmbH - Overview
  • 58: Croma Pharma GmbH - Business segments
  • 59: Croma Pharma GmbH - Key offerings
  • 60: Croma Pharma GmbH - Key customers
  • 61: Croma Pharma GmbH - Segment focus
  • 62: Galderma SA - Overview
  • 63: Galderma SA - Product and service
  • 64: Galderma SA - Key offerings
  • 65: Galderma SA - Key customers
  • 66: Galderma SA - Segment focus
  • 67: Hangzhou Techderm Biological Products Co. Ltd. - Overview
  • 68: Hangzhou Techderm Biological Products Co. Ltd. - Business segments
  • 69: Hangzhou Techderm Biological Products Co. Ltd. - Key offerings
  • 70: Hangzhou Techderm Biological Products Co. Ltd. - Key customers
  • 71: Hangzhou Techderm Biological Products Co. Ltd. - Segment focus
  • 72: Medytox Inc. - Overview
  • 73: Medytox Inc. - Business segments
  • 74: Medytox Inc. - Key offerings
  • 75: Medytox Inc. - Key customers
  • 76: Medytox Inc. - Segment focus
  • 77: Merz Pharma GmbH and Co. KGaA - Overview
  • 78: Merz Pharma GmbH and Co. KGaA - Product and service
  • 79: Merz Pharma GmbH and Co. KGaA - Key offerings
  • 80: Merz Pharma GmbH and Co. KGaA - Key customers
  • 81: Merz Pharma GmbH and Co. KGaA - Segment focus
  • 82: Prollenium Medical Technologies Inc. - Overview
  • 83: Prollenium Medical Technologies Inc. - Business segments
  • 84: Prollenium Medical Technologies Inc. - Key offerings
  • 85: Prollenium Medical Technologies Inc. - Key customers
  • 86: Prollenium Medical Technologies Inc. - Segment focus
  • 87: Sinclair Pharma Group - Overview
  • 88: Sinclair Pharma Group - Business segments
  • 89: Sinclair Pharma Group - Key offerings
  • 90: Sinclair Pharma Group - Key customers
  • 91: Sinclair Pharma Group - Segment focus
  • 92: Suneva Medical - Overview
  • 93: Suneva Medical - Product and service
  • 94: Suneva Medical - Key offerings
  • 95: Suneva Medical - Key customers
  • 96: Suneva Medical - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations